Connect with us

Health

Naïve B cells can neutralize SARS-CoV-2 via RBD recognition – News-Medical.Net

A new preprint research paper posted to the bioRxiv server demonstrates the potential of using the pre-existing protective responses to produce a broad-spectrum…

Published

on

post featured image

Even as vaccination is being rolled out against the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), scientists grapple with the threat of new and more transmissible variants, which may be resistant to the antibodies elicited by either natural infection or vaccination. This would severely endanger the achievement of population immunity, the goal of vaccination, and the hope of a return to everyday pre-pandemic life.
A new preprint…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending